On-demand treatment that helps you fight back

For people taking carbidopa/levodopa for Parkinson's disease (PD) and experiencing
the return of symptoms between regular doses of medication, adding INBRIJA can help.
In a large clinical trial, INBRIJA started improving motor symptoms in as early as 10 minutes
and significant relief in motor symptoms was seen in 30 minutes of taking INBRIJA.
INBRIJA is an inhaled form of the levodopa in your regular carbidopa/levodopa PD medication. INBRIJA does not replace your regular carbidopa/levodopa medicine.
*1 dose (2 capsules) per OFF
period up to 5 times per day.
I’ve been using it a couple of years now and I’ll do it in front of anybody, in a restaurant or anywhere. And it’s allowed me to have Parkinson’s and still be able to go out…
—Jimmy, person with Parkinson's
INBRIJA is used in addition to your usual Parkinson's medications. It may start to work in as
little as 10 minutes. In a large study, significant relief in motor symptoms was seen in
30 minutes of taking INBRIJA.
Take it as prescribed when your symptoms return (OFF periods). Use 1 dose (2 capsules) per OFF period and no more than 5 doses (10 capsules) per day.
INBRIJA is easy to carry with you. Store your INBRIJA at room temperature 68°F to 77°F (20 °C to 25 °C) in a dry place.
Keep the capsules in their foil (blister) packages until just before you're ready to use them.
Talk to your doctor about a $0 initial co-pay† for INBRIJA
†Limitations and restrictions apply.INBRIJA is an inhaled levodopa prescription medicine used to treat the return of Parkinson’s symptoms (known as OFF episodes) in people with Parkinson’s disease who are treated with carbidopa/levodopa medicines. INBRIJA does not replace regular carbidopa/levodopa medicine. It is not known if INBRIJA is safe or effective in children.
Do not use INBRIJA if you: take or have taken a nonselective monoamine oxidase inhibitor such as phenelzine or tranylcypromine within the last 2 weeks.
Before using INBRIJA, tell your healthcare provider about your medical conditions, including if you:
Tell your healthcare provider about all of the medicines you take, including prescription and over-the-counter medicines, vitamins and herbal supplements.
Using INBRIJA and certain other medicines may affect each other and cause serious side effects. Especially tell your healthcare provider if you take:
INBRIJA is for oral inhalation use only. Do not swallow or open INBRIJA capsules. Only use INBRIJA capsules with the INBRIJA inhaler. Do not use the INBRIJA inhaler to take any other medicine.
Do not orally inhale more than 1 dose (2 capsules) for any OFF period. Do not take more than 5 doses (10 capsules) in a day.
Do not drive, operate machinery, or do other activities until you know how INBRIJA affects you. Sleepiness and falling asleep suddenly can happen as late as a year after treatment is started.
INBRIJA can cause serious side effects including:
The most common side effects of INBRIJA are cough, upper respiratory tract infection, nausea, and change in the color of saliva or spit. Another side effect of INBRIJA is sensation of choking right after use.
These are not all the possible side effects of INBRIJA
The risk information provided here is not comprehensive. To learn more:
Treats OFF periods in adults taking carbidopa/levodopa (CD/LD). INBRIJA doesn't replace CD/LD.
Don't use if you have taken a nonselective monoamine oxidase inhibitor (eg, phenelzine, tranylcypromine) within the last 2 weeks.